Keryx Biopharma (KERX) Files $100M Mixed Securities Shelf
Keryx Biopharma (Nasdaq: KERX) filed for a $100 million mixed securities shelf.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keryx Biopharmaceuticals Announces Ferric Citrate Presentations at the Upcoming American Society of Nephrology Kidney Week 2014 Annual Meeting
- Galena Biopharma (GALE) Files 2M Common Shelf for Shareholder
- General Finance (GFN) Files $250M Mixed Shelf
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!